These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35784679)

  • 1. Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy.
    Yu XB; Zhang XS; Wang YX; Wang YZ; Zhou HM; Xu FM; Yu JH; Zhang LW; Dai Y; Zhou ZY; Zhang CH; Lin GY; Pan JY
    Front Pharmacol; 2022; 13():915958. PubMed ID: 35784679
    [No Abstract]   [Full Text] [Related]  

  • 2. Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients.
    Xie YL; Jin X; Yan SS; Wu CF; Xiang BX; Wang H; Liang W; Yang BC; Xiao XF; Li ZL; Pei Q; Zuo XC; Peng Y
    Front Pharmacol; 2022; 13():967412. PubMed ID: 36105229
    [No Abstract]   [Full Text] [Related]  

  • 3. Population pharmacokinetic analysis, renal safety, and dosing optimization of polymyxin B in lung transplant recipients with pneumonia: A prospective study.
    Cai XJ; Chen Y; Zhang XS; Wang YZ; Zhou WB; Zhang CH; Wu B; Song HZ; Yang H; Yu XB
    Front Pharmacol; 2022; 13():1019411. PubMed ID: 36313312
    [No Abstract]   [Full Text] [Related]  

  • 4. Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant
    Saelim W; Changpradub D; Thunyaharn S; Juntanawiwat P; Nulsopapon P; Santimaleeworagun W
    Infect Chemother; 2021 Mar; 53(1):128-140. PubMed ID: 34409786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of colistimethate sodium in critical patients: an in vitro study by using of Monte Carlo simulation].
    Pan A; Mei Q; Yang T; Gao X; Lu H; Ye Y; Li J; Liu B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 May; 29(5):385-389. PubMed ID: 28524024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.
    Karnik ND; Sridharan K; Jadhav SP; Kadam PP; Naidu RK; Namjoshi RD; Gupta V; Gore MS; Surase PV; Mehta PR; Gogtay JA; Thatte UM; Gogtay NJ
    Eur J Clin Pharmacol; 2013 Jul; 69(7):1429-36. PubMed ID: 23508665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colistin Dosing Regimens against
    Nguyen VTK; Montakantikul P; Tragulpiankit P; Houngsaitong J; Shuib MF
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34067716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
    Jacobs M; Grégoire N; Mégarbane B; Gobin P; Balayn D; Marchand S; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1788-93. PubMed ID: 26729492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal empiric treatment for KPC-2-producing Klebsiella pneumoniae infections in critically ill patients with normal or decreased renal function using Monte Carlo simulation.
    Wang G; Yu W; Cui Y; Shi Q; Huang C; Xiao Y
    BMC Infect Dis; 2021 Mar; 21(1):307. PubMed ID: 33771113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses.
    Antachopoulos C; Geladari A; Landersdorfer CB; Volakli E; Ilia S; Gikas E; Gika H; Sdougka M; Nation RL; Roilides E
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33782000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study.
    Moni M; Sudhir AS; Dipu TS; Mohamed Z; Prabhu BP; Edathadathil F; Balachandran S; Singh SK; Prasanna P; Menon VP; Patel T; Patel P; Kaye KS; Menon VP
    Int J Infect Dis; 2020 Nov; 100():497-506. PubMed ID: 32781161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients.
    Zheng Y; Xu B; Chen S; Liu M; Huang H; Wang J; Wu X
    J Clin Pharmacol; 2023 Sep; 63(9):1036-1044. PubMed ID: 37125471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen.
    Fan Y; Li Y; Chen Y; Yu J; Liu X; Li W; Guo B; Li X; Wang J; Wu H; Wang Y; Hu J; Guo Y; Hu F; Xu X; Cao G; Wu J; Zhang Y; Zhang J; Wu X
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical.
    Sorlí L; Luque S; Li J; Campillo N; Danés M; Montero M; Segura C; Grau S; Horcajada JP
    J Infect; 2019 Sep; 79(3):253-261. PubMed ID: 31265867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
    Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant
    Jitaree K; Sathirakul K; Houngsaitong J; Asuphon O; Saelim W; Thamlikitkul V; Montakantikul P
    Antibiotics (Basel); 2019 Aug; 8(3):. PubMed ID: 31443514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage Strategy of Linezolid According to the Trough Concentration Target and Renal Function in Chinese Critically Ill Patients.
    Wu F; Zhang XS; Dai Y; Zhou ZY; Zhang CH; Han L; Xu FM; Wang YX; Shi DW; Lin GY; Yu XB; Chen F
    Front Pharmacol; 2022; 13():844567. PubMed ID: 35479324
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjects.
    Mizuyachi K; Hara K; Wakamatsu A; Nohda S; Hirama T
    Curr Med Res Opin; 2011 Dec; 27(12):2261-70. PubMed ID: 21995648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic and optimization of polymyxin B dosing in adult patients with various renal functions.
    Yu XB; Jiao Z; Zhang CH; Dai Y; Zhou ZY; Han L; Wen X; Sheng CC; Lin GY; Pan JY
    Br J Clin Pharmacol; 2021 Apr; 87(4):1869-1877. PubMed ID: 33002196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.